dyspepsia
DYSPEPSIA

Dyspepsia is having any one of the following: Disturbing postprandial fullness, early satiation, epigastric pain and/or burning felt predominantly in the upper abdomen.

It is considered a symptom complex rather than a specific diagnosis.

Acid suppression is the recommended initial therapy.

Specialist Referral

  • Specialist investigation is necessary for patients ≥60 years (younger in areas with high prevalence of gastric cancer), patients with alarm symptoms, patients who did not respond to empiric therapy and have persistent symptoms, and for further evaluation of an alternate diagnosis  

Endoscopy

  • Upper GI endoscopy is the investigation of choice when further evaluation is warranted
  • Endoscopy allows a clinician to view the GIT and, if necessary, perform diagnostic and therapeutic procedures, eg biopsy
  • Routine endoscopic investigation of patients <60 years old, presenting with dyspepsia and with or without alarm signs, is not necessary; consideration for endoscopy should be on a case-by-case basis per physician’s clinical judgment  
  • Should be reserved for patients who have little or no response to therapy after 7-10 days or for patients whose symptoms have not resolved after 4-8 weeks
    • If upper GI endoscopy is unremarkable, patients with persistent symptoms or alarm features should be evaluated further for other diagnosis
  • Depending on local protocol: For patients ≥60 years (younger in areas with high prevalence of gastric cancer), consider endoscopy when symptoms persist despite H pylori testing/treatment and acid suppression therapy, and when patient has one or more of:
    • Previous gastric ulcer or surgery
    • Continuing need for NSAID treatment
    • Raised risk of gastric cancer
    • Anxiety about cancer
  • Patients undergoing endoscopy should be free from medication with either a PPI or H2RA for a minimum of 2 weeks

Follow Up

  • Offer low-dose PPI or H2RA treatment with limited number of prescriptions or stopping treatment
    • Dyspepsia is a remitting and relapsing disease and continuous medication is not necessary after eradication of symptoms unless there is an underlying condition requiring treatment
  • May consider treatment with antacids when necessary
  • Continue to avoid known precipitants of dyspepsia including smoking, alcohol, coffee, chocolate, fatty foods and being overweight, and to adhere to lifestyle modifications
  • Monitor for appearance of alarm signs and symptoms
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
15 Jul 2019
Fluticasone, swallowed from a multidose inhaler, and oral viscous budesonide slurry have comparable efficacies as initial treatment for eosinophilic oesophagitis, a recent study has found.
31 May 2019
Co-therapy with proton pump inhibitors (PPIs) in patients receiving low-dose anticoagulation and/or aspirin for stable cardiovascular disease confers no benefit for upper gastrointestinal events but may reduce bleeding due to gastroduodenal lesions, a study has shown.
29 Jun 2019
Monotherapy with a proton pump inhibitor appears to be effective in the treatment of functional dyspepsia symptoms associated with gastro-oesophageal reflux disease, according to a study.
07 Aug 2019
The combination of metformin, nystatin, linagliptin, rivaroxaban and a high-protein diet is the main cause of nasoenteral tube obstruction, with corresponding odds ratios of 2.0, 3.1, 4.3, 2.4 and 1.9, according to a recent study.